Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system. The immune system attacks myelin, the protective sheath covering nerve fibers, causing communication problems between the brain and body. MS can cause a wide variety of symptoms and may lead to permanent disability in some cases.
Prevalence
MS affects approximately 2.8 million people worldwide and nearly 1 million adults in the United States. It is typically diagnosed between ages 20-50.
Who It Affects
Women are 2-3 times more likely to develop MS than men. Risk factors include genetics, low vitamin D, smoking, certain infections (Epstein-Barr virus), and living in temperate climates farther from the equator.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Disease-Modifying Therapies (DMTs)
Medications that reduce relapse frequency and slow disease progression.
Limitations: Many options with varying efficacy and side effects. Most effective early in disease. Do not reverse existing damage.
Corticosteroids
High-dose steroids to reduce inflammation during acute relapses.
Limitations: Treat relapses but do not affect long-term disease course. Side effects limit use.
Symptom Management
Medications for fatigue, spasticity, pain, bladder issues, and other symptoms.
Limitations: Addresses symptoms but not underlying disease process.
Physical and Occupational Therapy
Rehabilitation to maintain function, mobility, and independence.
Limitations: Essential but cannot prevent disease progression.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for multiple sclerosis is an active area of research exploring whether biologics may have immunomodulatory effects and potentially support myelin health. Some stem cell approaches (like HSCT) are being studied in clinical trials, while other regenerative therapies remain highly experimental for MS.
Potential Benefits Being Studied:
- Being studied for potential immunomodulatory effects
- Research exploring support for myelin-producing cells
- May help modulate the autoimmune process (under investigation)
- An area of active clinical research
- Some stem cell trials showing promising early results
- Does not replace disease-modifying therapy
Biologics Used:
Mesenchymal stem cells being studied in clinical trials
Hematopoietic stem cell transplantation (HSCT) in select cases
Frequently Asked Questions
Can stem cells cure MS?
There is currently no cure for MS. Some stem cell approaches are being studied in clinical trials with promising early results, but they remain experimental. Never stop prescribed MS medications without neurologist guidance.
Is this different from HSCT?
Yes. HSCT (hematopoietic stem cell transplantation) is a more intensive procedure being studied for aggressive MS. Other regenerative approaches use different cell types and mechanisms. Discuss options with an MS specialist.
Should I stop my DMT medications?
No. Never stop or change disease-modifying therapy without consulting your neurologist. Any regenerative approach would be considered as a potential complement to, not replacement for, standard MS care.
Ready to Explore Your Options?
Schedule a free consultation to discuss multiple sclerosis and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for multiple sclerosis are highly investigational. MS requires ongoing management by a neurologist. Never discontinue prescribed MS medications. Discuss any experimental treatments with your MS care team.